CN Patent

CN102630174A — 用于药物递送装置的驱动机构和用于驱动机构的重置构件

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2012-08-08 · 14y expired

What this patent protects

柱塞(4)和杆(5)布置主体(1)内，并且设置有将杆与柱塞接合的接合元件。所述杆能够通过杆的移动与柱塞脱离，由此使得柱塞能够相对于主体沿近端方向(30)运动。

USPTO Abstract

柱塞(4)和杆(5)布置主体(1)内，并且设置有将杆与柱塞接合的接合元件。所述杆能够通过杆的移动与柱塞脱离，由此使得柱塞能够相对于主体沿近端方向(30)运动。

Drugs covered by this patent

testosterone-enanthate (TESTOSTERONE ENANTHATE)

Patent Metadata

Patent number: CN102630174A
Jurisdiction: CN
Classification: —
Expires: 2012-08-08
Drug substance claim: No
Drug product claim: No
Assignee: Sanofi Aventis Deutschland GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.